Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04642612 · ClinicalTrials.gov registry record
Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT04642612: Clinical Trial study, sponsored by Stanford University.
NCT04642612 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04642612 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess cerebral blood flow velocity (CBFV) following regional anesthesia for shoulder surgery. The results of this study will help to further understand the physiologic effect of the interscalene nerve block on cerebral blood flow.
Interventions
- DEVICE TCD Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-03-04 |
| Est. Completion | 2021-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04642612
The ClinicalTrials.gov registry entry for NCT04642612 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TCD Measurement is the first listed.
NCT04642612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04642612 about?
NCT04642612 is a clinical study titled "Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block". The purpose of this study is to assess cerebral blood flow velocity (CBFV) following regional anesthesia for shoulder surgery. The results of this study will help to further understand the physiologic effect of the interscalene nerve block on cerebral blood flow.
What is the current status of trial NCT04642612?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2021-03-04. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT04642612?
The interventions under investigation include: TCD Measurement (DEVICE).
Who is sponsoring clinical trial NCT04642612?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.